Cash Flow Statement

Amortizatization of Intangibles Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Account Payables Change in Accured Expenses Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Free Cash Flow Gains from Investment Securities Gains from Sales and Divestitures Net Cash Flow Net Income Non-cash Items Other Working Capital Changes Other financing activities Share-based Compensation

Daily Values

Growth Metrics

Others

Ratios

Evommune (EVMN) Amortizatization of Intangibles (2024 - 2025)

Evommune (EVMN) has disclosed Amortizatization of Intangibles for 2 consecutive years, with $585000.0 as the latest value for Q4 2025.